Relapse Versus Reinfection: Surveillance of Clostridium difficile Infection

被引：67

作者：

Kamboj, Mini ^{[1
,2
]}

Khosa, Perminder ^{[2
]}

Kaltsas, Anna ^{[1
]}

Babady, N. Esther ^{[3
]}

Son, Crystal ^{[2
]}

Sepkowitz, Kent A. ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10065 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA

[3] Mem Sloan Kettering Canc Ctr, Microbiol Serv, Dept Clin Labs, New York, NY 10065 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2011年 / 53卷 / 10期

关键词：

MOLECULAR ANALYSIS; DIARRHEA; RECURRENCES; EPIDEMIC; DISEASE; STRAIN;

D O I：

10.1093/cid/cir643

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Molecular typing was used to examine surveillance definitions for recurrent Clostridium difficile-associated diarrhea. Among 102 patients, 85 had a second episode within 8 weeks, 88% of which were relapses. Of 49 second episodes occurring after > 8 weeks, 65% were relapses. Categorization of a recurrent episode occurring after >8 weeks as a new infection may misrepresent the majority of episodes for surveillance.

引用

页码：1003 / 1006

页数：4

共 50 条

[1] CLOSTRIDIUM DIFFICILE RELAPSE VERSUS REINFECTION
JOHNSON, S
ADELMANN, A
CLABOTS, CR
PETERSON, LR
GERDING, DN
CLINICAL RESEARCH, 1987, 35 (06): : A897 - A897
[2] RELAPSE VERSUS REINFECTION WITH CLOSTRIDIUM-DIFFICILE
ONEILL, GL
BEAMAN, MH
RILEY, TV
EPIDEMIOLOGY AND INFECTION, 1991, 107 (03): : 627 - 635
[3] Recurrence of symptoms in Clostridium difficile infection - relapse or reinfection?
Wilcox, MH
Fawley, WN
Settle, CD
Davidson, A
JOURNAL OF HOSPITAL INFECTION, 1998, 38 (02) : 93 - 100
[4] Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
Figueroa, Iris
Johnson, Stuart
Sambol, Susan P.
Goldstein, Ellie J. C.
Citron, Diane M.
Gerding, Dale N.
CLINICAL INFECTIOUS DISEASES, 2012, 55 : S104 - S109
[5] Clostridium difficile Mixed Infection and Reinfection
Eyre, David W.
Walker, A. Sarah
Griffiths, David
Wilcox, Mark H.
Wyllie, David H.
Dingle, Kate E.
Crook, Derrick W.
Peto, Tim E. A.
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (01) : 142 - 144
[6] Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing
Zeng, Zhen
Zhao, Hailong
Dorr, Mary Beth
Shen, Judong
Wilcox, Mark H.
Poxton, Ian R.
Guris, Dalya
Li, Junhua
Shaw, Peter M.
ANAEROBE, 2020, 61
[7] Mouse Relapse Model of Clostridium difficile Infection
Sun, Xingmin
Wang, Haiying
Zhang, Yongrong
Chen, Kevin
Davis, Barbara
Feng, Hanping
INFECTION AND IMMUNITY, 2011, 79 (07) : 2856 - 2864
[8] Whole-Genome Sequencing Demonstrates That Fidaxomicin Is Superior to Vancomycin for Preventing Reinfection and Relapse of Infection With Clostridium difficile
Eyre, David W.
Babakhani, Farah
Griffiths, David
Seddon, Jaime
Elias, Carlos Del Ojo
Gorbach, Sherwood L.
Peto, Tim E. A.
Crook, DerrickW.
Walker, A. Sarah
JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (09): : 1446 - 1451
[9] Reinfection versus relapse in urinary tract infection
Johnson, JR
CLINICAL INFECTIOUS DISEASES, 2005, 40 (03) : 495 - 495
[10] Ideal Source for Surveillance of Clostridium difficile Infection; Billing versus Microbiology Database
Chandra, Subhash
Jariwala, Ujjval
Thapa, Rameet
Palabindala, Venkataraman
Elalem, Bobaker
Marur, Surendra
Jani, Niraj
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S201 - S201

← 1 2 3 4 5 →